Graf Akcie AXDX (Accelerate Diagnostics Inc). Diskuze k akciím AXDX. Aktuální informace AXDX.

Základní informace o společnosti Accelerate Diagnostics Inc (Akcie AXDX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 407.77M
Hodnota podniku (EV) N/A
Tržby 12.013M
EBITDA N/A
Zisk -83.58
Růst v tržbách Q/Q 31.67 %
Růst v tržbách Y/Y 17.68 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.07
EV/Sales 38.33
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 33.94
P/FCF N/A
Price/Book -6.49
Účetní hodnota na akcii -1.04
Hotovost na akcii 1.13
FCF vůči ceně -11.45 %
Počet zaměstnanců 224
Tržba na zaměstnance 53.629k
Profit margin -700.47 %
Operating margin -564.92 %
Gross margin 39.94 %
EBIT margin -560.60 %
EBITDA margin -609.36 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 2.86 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets -87.00 %
Return on equity 134.49 %
ROIC -55.00 %
ROCE -79.54 %
Dluhy/Equity -2.49
Čistý dluh/EBITDA -2.79
Current ratio 8.98
Quick Ratio 7.96
Volatilita 5.52
Beta 0.54
RSI 65.92
Cílová cena analytiků 15
Známka akcie (dle analytiků) 2.20
Insider ownership 45.14 %
Institutional ownership 40.14 %
Počet akcií 61.499M
Procento shortovaných akcií 22.95 %
Short ratio 66.02 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1996
Země United States

Finanční výsledky akcie AXDX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$9.297$5.67$4.177$0.246$0.147$0.122
Cost Of Goods Sold$4.897$3.187$1.002---
Gross Profit$4.4$2.483$3.175$0.246$0.147$0.122
Research And Development Expenses$25.345$27.638$22.301$29.564$27.142$19.526
SG&A Expenses$51.886$55.214$45.058$37.183$18.554$10.695
Other Operating Income Or Expenses------
Operating Expenses$82.128$86.039$68.361$66.747$45.696$31.112
Operating Income$-72.831$-80.369$-64.184$-66.501$-45.549$-30.99
Total Non-Operating Income/Expense$-11.585$-7.746$0.649$0.394$0.051$0.057
Pre-Tax Income$-84.416$-88.115$-63.535$-66.107$-45.498$-30.933
Income Taxes$-0.111$0.211$0.493$0.267--
Income After Taxes$-84.305$-88.326$-64.028$-66.374$-45.498$-30.933
Other Income------
Income From Continuous Operations$-84.305$-88.326$-64.028$-66.374$-45.498$-30.933
Income From Discontinued Operations------
Net Income$-84.305$-88.326$-64.028$-66.374$-45.498$-30.933
EBITDA$-60.687$-71.58$-61.662$-63.776$-43.569$-29.833
EBIT$-72.831$-80.369$-64.184$-66.501$-45.549$-30.99
Basic Shares Outstanding555454514544
Shares Outstanding555454514544
Basic EPS$-1.55$-1.62$-1.18$-1.29$-1.01$-0.71
EPS - Earnings Per Share$-1.55$-1.62$-1.18$-1.29$-1.01$-0.71
# 2020 2019 2018 2017 2016 2015
Current Ratio14.929222.882917.752819.437125.282924.11
Long-term Debt / Capital1.06020.6767---0.0002
Debt/Equity Ratio-17.62342.0928--0.00010.0024
Gross Margin47.327143.791976.0115100100100
Operating Margin-783.3818-1417.443-1536.605-27032.92-30985.71-25401.64
EBIT Margin-783.3818-1417.443-1536.605-27032.92-30985.71-25401.64
EBITDA Margin-652.759-1262.434-1476.227-25925.2-29638.78-24453.28
Pre-Tax Profit Margin-907.9918-1554.056-1521.068-26872.76-30951.02-25354.92
Net Profit Margin-906.7979-1557.778-1532.87-26981.3-30951.02-25354.92
Asset Turnover0.06920.03060.03330.0030.00110.0017
Inventory Turnover Ratio0.60760.41140.1243---
Receiveable Turnover2.88553.04842.14657.23531.90911.5641
Days Sales In Receivables126.4956119.7355170.047950.4472191.1905233.3607
ROE - Return On Equity1142.494-153.9451-53.9392-85.2961-34.2044-46.8746
Return On Tangible Equity1142.499-153.9451-54.0002-85.4564-34.2448-46.9935
ROA - Return On Assets-62.7157-47.6755-51.0135-80.1115-32.6563-44.316
ROI - Return On Investment-68.7284-49.7754-53.9392-85.2961-34.2044-46.8654
Book Value Per Share-0.13491.0582.13211.51052.59851.4783
Operating Cash Flow Per Share0.0546-0.21250.0107-0.261-0.35-0.1713
Free Cash Flow Per Share0.0669-0.17590.0028-0.2267-0.387-0.1848